Thompson Craig B.
SEC CIK 1423419 · EDGAR
Most active insiders at CRL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FOSTER JAMES C | Dir | — | $34.84M |
| 2 | Parisotto Shannon M | CEVP, Disc, Safety Assessment | — | $2.97M |
| 3 | Girshick Birgit | COO, Corp. Executive VP | — | $1.82M |
| 4 | Knell Michael Gunnar | SVP, CAO, Fin | — | $1.73M |
| 5 | Creamer Victoria L | EVP, CHRO | — | $1.08M |
| 6 | Andrews Nancy C | Dir | — | $163.4K |
| 7 | LaPlume Joseph W | EVP, Corp Strategy, Develop | $4,364 | — |
| 8 | Mintz Mark | EVP, CIO | — | — |
| 9 | Kemps-Polanco Reshema | Dir | — | — |
| 10 | Barg Steven | Dir | — | — |
| 16 | Thompson Craig B. | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-12 16:22 | 2026-05-08 | CRL | Charles River Laboratories | Thompson Craig B. | Dir | A - Grant | $177.62 | +1,438 | 3,851 | +60% | +$255.4K | |
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | Thompson Craig B. | Dir | A - Grant | $0.00 | +155 | 775 | +25% | $0 |
| D | 2025-05-23 | 2025-05-21 | CRL | Charles River Laboratories | Thompson Craig B. | Dir | A - Grant | $134.98 | +946 | 2,413 | +64% | +$127.7K |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | Thompson Craig B. | Dir | A - Grant | $0.00 | +166 | 620 | +37% | $0 |
| D | 2024-05-15 | 2024-05-13 | CRL | Charles River Laboratories | Thompson Craig B. | Dir | A - Grant | $228.41 | +559 | 1,467 | +62% | +$127.7K |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | Thompson Craig B. | Dir | A - Grant | $0.00 | +135 | 454 | +42% | $0 |
| D | 2023-05-17 | 2023-05-15 | CRL | Charles River Laboratories | Thompson Craig B. | Dir | A - Grant | $0.00 | +664 | 908 | +272% | $0 |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | Thompson Craig B. | Dir | A - Grant | $0.00 | +40 | 319 | +14% | $0 |
| D | 2023-01-04 | 2023-01-03 | CRL | Charles River Laboratories | Thompson Craig B. | Dir | A - Grant | $0.00 | +244 | 244 | New | $0 |
| D | 2022-10-05 | 2022-10-03 | REGN | Regeneron Pharmaceuticals | Thompson Craig B. | Dir | A - Grant | $0.00 | +279 | 279 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations